Cargando…
Recent advances in understanding cholangiocarcinoma
The definition of cholangiocarcinoma (CCA) encompasses all tumors originating in the epithelium of the bile ducts, including the intrahepatic bile ducts (ICCA) and extrahepatic bile ducts (ECCA). The incidence of ICCA and ECCA has increased in the last few decades, and molecular advances in both ent...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculty Opinions Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886064/ https://www.ncbi.nlm.nih.gov/pubmed/33659947 http://dx.doi.org/10.12703/b/9-15 |
_version_ | 1783651718354960384 |
---|---|
author | Uson Junior, Pedro Luiz Serrano Arora, Mansi Bogenberger, James M Borad, Mitesh J |
author_facet | Uson Junior, Pedro Luiz Serrano Arora, Mansi Bogenberger, James M Borad, Mitesh J |
author_sort | Uson Junior, Pedro Luiz Serrano |
collection | PubMed |
description | The definition of cholangiocarcinoma (CCA) encompasses all tumors originating in the epithelium of the bile ducts, including the intrahepatic bile ducts (ICCA) and extrahepatic bile ducts (ECCA). The incidence of ICCA and ECCA has increased in the last few decades, and molecular advances in both entities have brought understanding of their differences and allowed treatment advances aimed at personalized therapy. In this review, we discuss recent progress in the molecular landscape of CCAs, emerging treatment biomarker-guided strategies, and future insights into the management of advanced disease. |
format | Online Article Text |
id | pubmed-7886064 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Faculty Opinions Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-78860642021-03-02 Recent advances in understanding cholangiocarcinoma Uson Junior, Pedro Luiz Serrano Arora, Mansi Bogenberger, James M Borad, Mitesh J Fac Rev Review Article The definition of cholangiocarcinoma (CCA) encompasses all tumors originating in the epithelium of the bile ducts, including the intrahepatic bile ducts (ICCA) and extrahepatic bile ducts (ECCA). The incidence of ICCA and ECCA has increased in the last few decades, and molecular advances in both entities have brought understanding of their differences and allowed treatment advances aimed at personalized therapy. In this review, we discuss recent progress in the molecular landscape of CCAs, emerging treatment biomarker-guided strategies, and future insights into the management of advanced disease. Faculty Opinions Ltd 2020-11-19 /pmc/articles/PMC7886064/ /pubmed/33659947 http://dx.doi.org/10.12703/b/9-15 Text en Copyright: © 2020 Borad MJ et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Uson Junior, Pedro Luiz Serrano Arora, Mansi Bogenberger, James M Borad, Mitesh J Recent advances in understanding cholangiocarcinoma |
title | Recent advances in understanding cholangiocarcinoma |
title_full | Recent advances in understanding cholangiocarcinoma |
title_fullStr | Recent advances in understanding cholangiocarcinoma |
title_full_unstemmed | Recent advances in understanding cholangiocarcinoma |
title_short | Recent advances in understanding cholangiocarcinoma |
title_sort | recent advances in understanding cholangiocarcinoma |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886064/ https://www.ncbi.nlm.nih.gov/pubmed/33659947 http://dx.doi.org/10.12703/b/9-15 |
work_keys_str_mv | AT usonjuniorpedroluizserrano recentadvancesinunderstandingcholangiocarcinoma AT aroramansi recentadvancesinunderstandingcholangiocarcinoma AT bogenbergerjamesm recentadvancesinunderstandingcholangiocarcinoma AT boradmiteshj recentadvancesinunderstandingcholangiocarcinoma |